S-1 · resale registration
Issued 2025
Proposed maximum
Shares registered
- Filed
- Effective
Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: USExchange: Nasdaq
DilutionScan read 43 of Cadrenal Therapeutics, Inc.'s SEC filings and found 17 warrant series, 1 ATM program, 4 shelf registrations, 1 S-1 registration and 3 completed offerings on file for CVKD. The latest dilution event on file is a registration statement on Jul 20, 2026. Analysis updated Nov 2, 2026.
Raise routes on file: active ATM + effective shelf + effective S-1 · latest dilution event 106 days ago
The dominant contractual driver and its mechanism, then each further driver ranked.
Jul 20, 2026 · Registration
Every warrant, convertible, ATM and shelf, cited to the filing
A free account reads 3 tickers a day in full
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
Shares outstanding, potential dilution and cash over time
Issued 2025
Proposed maximum
Shares registered
Shares Underlying
Exercise Price
Shares Underlying
Exercise Price
Shares Underlying
Exercise Price
Shares Underlying
Exercise Price
Issued 2024
Shares Underlying
Exercise Price
Issued 2024
Shares Underlying
Exercise Price
Issued 2024
Total capacity
Sold to date
Issued 2024
Total capacity
Remaining
Issued 2024
Total capacity
Remaining
Issued 2026
Total capacity
Remaining
Issued 2026
Total capacity
Remaining
Issued 2026
Gross proceeds
Price per share
Issued 2026
Gross proceeds
Price per share
Issued 2025
Gross proceeds
Price per share
Exercise prices, conversion terms, shelf headroom and the filing sentence behind every number.
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
DilutionScan ProEvery instrument in full · $59/mo
Covered companies in Biotechnology. All tickers A to Z